Study on Microchannel Design and Burst Frequency Detection for Centrifugal Microfluidic System

A centrifugal microfluidic system has been developed in this study, enabling the control and measurement of the burst frequency in order to manipulate the liquid. The radial microfluid chips with different microchannel dimensions were designed for simulation analyses and experimental verifications. The microfluidic flow in the microchannel was analyzed using software CFDRC, providing an accurate result compared with that from experiment. The results show that the design of the overflow microchannel can correctly keep the liquid volume with error as low as 5%. For mercurochrome, the burst frequency has an inverse proportion to the channel width, and the simulation results agree with the experimental results. For oil, however, the experimental and simulation results indicate that the relationship between the burst frequency and channel width is not obvious due to oil properties. Since the simulation approach can provide an accurate prediction of flow behavior in the microchannel, the design of radial microfluid chip and the control of burst frequency can be achieved effectively. A practical application to design the centrifugal microfluidic disc for blood typing test was also carried out in this study. The centrifugal microfluidic system can successfully control the spinning speed to achieve the result of adding reagents in a specific sequence

EFFECTS OF POLYMER MORPHOLOGY ON THE RHEOLOGICAL BEHAVIOR OF MELT WITHIN MICRO-CHANNELS

ABSTRACT Micro molding has shown great commercial potential in recent years and determination of the rheological behavior of the polymer melt within micro structured geometry is vital for accurate simulation modeling of micro molding. The lack of commercial equipment is one of main hurdles in the investigation of micro melt rheology. In this study, a melt viscosity measurement system for low and high density polyethylene polymer melt flowing through micro-channels was established using a micro channel mold operated at a mold temperature as high as the melt temperature. For measured pressure drop and volumetric flow rate, capillary flow model was used for the calculation of viscosity utilizing Rabinowitsch correction. The calculated results of low crystallinity LDPE resin were also compared with those of high crystallinity HDPE resin to discuss the effect of degree of crystallinity on the viscosity characteristics of polymer within micro-channels. It was found that the measured LDPE and HDPE viscosity values in the test ranges are significantly lower (about 40~56% and 22~29% for LDPE and HDPE, respectively, flowing through a channel size of 150μm) than those obtained with a traditional capillary rheometer. Meanwhile, the percentage reduction in the viscosity value and the ratio of slip velocity relative to mean velocity all increase with decreasing micro-channel size. In the present study we emphasize that the rheological behavior of the high crystallinity HDPE and low crystallinity LDPE resins in microscopic scale are all different from that of macroscopic scale but HDPE displays a less significant lower. The reason can be attributed to for LDPE resin within the micro-channel can create the higher extra bonding force between the bulk chains than HDPE resin. Thus, it will have the lower adhesive force between the bulk chains with the micro-channel wall, resulting in higher degree of wall slip

Comparison of extracorporeal shock wave lithotripsy running models between outsourcing cooperation and rental cooperation conducted in Taiwan

Background/PurposeWe conducted a retrospective study to compare the cost and effectiveness between two different running models for extracorporeal shock wave lithotripsy (SWL), including the outsourcing cooperation model (OC) and the rental cooperation model (RC).MethodsBetween January 1999 and December 2005, we implemented OC for the SWL, and from January 2006 to October 2011, RC was utilized. With OC, the cooperative company provided a machine and shared a variable payment with the hospital, according to treatment sessions. With RC, the cooperative company provided a machine and received a fixed rent from the hospital. We calculated the cost of each treatment session, and evaluated the break-even point to estimate the lowest number of treatment sessions to make the balance between revenue and cost every month. Effectiveness parameters, including the stone-free rate, the retreatment rate, the rate of additional procedures and complications, were evaluated.ResultsCompared with OC there were significantly less treatment sessions for RC every month (42.6±7.8 vs. 36.8±6.5, p=0.01). The cost of each treatment session was significantly higher for OC than for RC (751.6±20.0 USD vs. 684.7±16.7 USD, p=0.01). The break-even point for the hospital was 27.5 treatment sessions/month for OC, when the hospital obtained 40% of the payment, and it could be reduced if the hospital got a greater percentage. The break-even point for the hospital was 27.3 treatment sessions/month for RC. No significant differences were noticed for the stone-free rate, the retreatment rate, the rate of additional procedures and complications.ConclusionOur study revealed that RC had a lower cost for every treatment session, and fewer treatment sessions of SWL/month than OC. The study might provide a managerial implication for healthcare organization managers, when they face a situation of high price equipment investment

In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: Definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides

Protein sumoylation by small ubiquitin-like modifier (SUMO) proteins is an important post-translational regulatory modification. A role in the control of chromosome dynamics was first suggested when SUMO was identified as high-copy suppressor of the centromere protein CENP-C mutants. CENP-C itself contains a consensus sumoylation sequence motif that partially overlaps with its DNA binding and centromere localization domain. To ascertain whether CENP-C can be sumoylated, tandem mass spectrometry (MS) based strategy was developed for high sensitivity identification and sequencing of sumoylated isopeptides present among in-gel-digested tryptic peptides of SDS-PAGE fractionated target proteins. Without a predisposition to searching for the expected isopeptides based on calculated molecular mass and relying instead on the characteristic MS/MS fragmentation pattern to identify sumolylation, we demonstrate that several other lysine residues located not within the perfect consensus sumoylation motif {psi}KXE/D, where {psi} represents a large hydrophobic amino acid, and X represnts any amino acid, can be sumolylated with a reconstituted in vitro system containing only the SUMO proteins, E1-activating enzyme and E2-conjugating enzyme (Ubc9). In all cases, target sites that can be sumoylated by SUMO-2 were shown to be equally susceptible to SUMO-1 attachments which include specific sites on SUMO-2 itself, Ubc9, and the recombinant CENP-C fragments. Two non-consensus sites on one of the CENP-C fragments were found to be sumoylated in addition to the predicted site on the other fragment. The developed methodologies should facilitate future studies in delineating the dynamics and substrate specificities of SUMO-1/2/3 modifications and the respective roles of E3 ligases in the process

A review on the molecular diagnostics of Lynch syndrome: A central role for the pathology laboratory

Lynch syndrome (LS) is caused by mutations in mismatch repair genes and is characterized by a high cumulative risk for the development of mainly colorectal carcinoma and endometrial carcinoma. Early detection of LS is important since surveillance can reduce morbidity and mortality. However, the diagnosis of LS is complicated by the absence of a pre-morbid phenotype and germline mutation analysis is expensive and time consuming. Therefore it is standard practice to precede germline mutation analysis by a molecular diagnostic work-up of tumours, guided by clinical and pathological criteria, to select patients for germline mutation analysis. In this review we address these molecular analyses, the central role for the pathologist in the selection of patients for germline diagnostics of LS, as well as the molecular basis of LS

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome

Background Lynch syndrome (LS) is an inherited autosomal dominant disorder characterised by an increased risk of colorectal cancer (CRC) and other cancers, and caused by mutations in the deoxyribonucleic acid (DNA) mismatch repair genes. Objective To evaluate the accuracy and cost-effectiveness of strategies to identify LS in newly diagnosed early-onset CRC patients (aged < 50 years). Cascade testing of relatives is employed in all strategies for individuals in whom LS is identified. Data sources and methods Systematic reviews were conducted of the test accuracy of microsatellite instability (MSI) testing or immunohistochemistry (IHC) in individuals with CRC at risk of LS, and of economic evidence relating to diagnostic strategies for LS. Reviews were carried out in April 2012 (test accuracy); and in February 2012, repeated in February 2013 (economic evaluations). Databases searched included MEDLINE (1946 to April week 3, 2012), EMBASE (1980 to week 17, 2012) and Web of Science (inception to 30 April 2012), and risk of bias for test accuracy was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) quality appraisal tool. A de novo economic model of diagnostic strategies for LS was developed. Results Inconsistencies in study designs precluded pooling of diagnostic test accuracy results from a previous systematic review and nine subsequent primary studies. These were of mixed quality, with significant methodological concerns identified for most. IHC and MSI can both play a part in diagnosing LS but neither is gold standard. No UK studies evaluated the cost-effectiveness of diagnosing and managing LS, although studies from other countries generally found some strategies to be cost-effective compared with no testing. The de novo model demonstrated that all strategies were cost-effective compared with no testing at a threshold of £20,000 per quality-adjusted life-year (QALY), with the most cost-effective strategy utilising MSI and BRAF testing [incremental cost-effectiveness ratio (ICER) = £5491 per QALY]. The maximum health benefit to the population of interest would be obtained using universal germline testing, but this would not be a cost-effective use of NHS resources compared with the next best strategy. When the age limit was raised from 50 to 60 and 70 years, the ICERs compared with no testing increased but remained below £20,000 per QALY (except for universal germline testing with an age limit of 70 years). The total net health benefit increased with the age limit as more individuals with LS were identified. Uncertainty was evaluated through univariate sensitivity analyses, which suggested that the parameters substantially affecting cost-effectiveness: were the risk of CRC for individuals with LS; the average number of relatives identified per index patient; the effectiveness of colonoscopy in preventing metachronous CRC; the cost of colonoscopy; the duration of the psychological impact of genetic testing on health-related quality of life (HRQoL); and the impact of prophylactic hysterectomy and bilateral salpingo-oophorectomy on HRQoL (this had the potential to make all testing strategies more expensive and less effective than no testing). Limitations The absence of high-quality data for the impact of prophylactic gynaecological surgery and the psychological impact of genetic testing on HRQoL is an acknowledged limitation. Conclusions Results suggest that reflex testing for LS in newly diagnosed CRC patients aged < 50 years is cost-effective. Such testing may also be cost-effective in newly diagnosed CRC patients aged < 60 or < 70 years. Results are subject to uncertainty due to a number of parameters, for some of which good estimates were not identified. We recommend future research to estimate the cost-effectiveness of testing for LS in individuals with newly diagnosed endometrial or ovarian cancer, and the inclusion of aspirin chemoprevention. Further research is required to accurately estimate the impact of interventions on HRQoL

Parameter Investigation of Nano-sized Etching in an ICP Silicon Etching System

[[abstract]]The effect of process parameters on the performance of silicon nano-sized etching in an Inductive-Coupled-Plasma Reactive-Ion-Etching (ICP-RIE) system is studied by the Taguchi experimental method. The Standard L9 orthogonal array is considered to evaluate the parameter effect and to obtain the optimum conditions. A total of 9 parameter settings are conducted to investigate the four parameters with three levels for each. The four parameters include the substrate temperature, bias power, gas cycle time and C4F8 gas flow rate. The source power and the SF6 gas flow rate are respectively fixed to a value of 500 W and 120 sccm. The etching bottom roughness and the etching rate are the quality characteristics to evaluate the parameter effect. The results show that both the C4F8 flow rate and the bias power have the significant influence on the bottom roughness, while both the cycle time and the bias power play an important role on etching rate. And, the optimum conditions are obtained, of which the predicted quality has been confirmed by verification experiment